Normal values of B type natriuretic peptide in infants, children, and adolescents

Heart

Volumn 89, Issue 8, 2003, Pages 875-878

  Koch, Andreas ^a,b   Singer, H ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE;

ADOLESCENCE; ADOLESCENT; ARTICLE; BODY MASS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; FLUORESCENCE; HUMAN; IMMUNOASSAY; INFANCY; INFANT; MALE; NEWBORN; NORMAL HUMAN; NORMAL VALUE; PLASMA; PRIORITY JOURNAL; PUBERTY; SEX DIFFERENCE;

EID: 0041742216     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.8.875     Document Type: Article

References (29)

1. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321-8.
2. Yoshimura M, Yasue H, Okamura, et al. Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993;87:464-9.
3. Yandle TG. Biochemistry of natriuretic peptides. J Intern Med 1994,235:561-76.
4. Nagagawa O, Ogawa Y, Itoh H, et al. Rapid transcriptional activation and early mRNA turnover of BNP in cardiocyte hypertrophy: evidence for BNP as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 1995;96:1280-7.
5. Maeda K, Takayoshi T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-32.
6. Kalra PR, Anker SD, Coats AJS. Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin. Cardiovasc Res 2001;51:495-509.
7. Struthers AD. Introducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only. Heart 2002;87:97-8.
8. Namakura T, Sakamoto K, Yamano T, et al. Increased plasma brain natriuretic peptide levels as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;39:1657-63.
9. Crilley JG, Farrer M. Left ventricular remodelling and brain natriuretic peptide after the first myocardial infarction. Heart 2001;86:638-42.
10. Matsuo K, Nishikimi T, Yutani C, et al. Diagnostic value of plasma levels of brain natriuretic peptide in arrhythmogenic right ventricular dysplasia. Circulation 199B;98:2433-40.
11. Kawamura T, Wago M. Brain natriuretic peptide can be a useful biochemical marker for myocarditis in patients with Kawasaki disease. Cardiol Young 2002;12:153-B.
12. Fischer Y, Filzmaier K, Stiegler H, et al. Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide. Clin Chem 2001;47:591-4.
13. Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in a urgent-core setting. J Am Coll Cardiol 2001;37:379-B5.
14. Wang TJ, Larson MG, Levy D, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002;90:254-8.
15. Kawamura T, Wago M, Kawaguchi H, et al. Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int 2000;42:241-8.
16. Yoshibayashi M, Kamiya T, Saito Y, et al. Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth. Eur J Endocrinol 1995;133:207-9.
17. Gemelli M, Mami C, DeLuca F, et al. Atrial natriuretic peptide and renin-aldosterone relationship in healthy newborn infants. Acta Paediatr Scand 1991;80:1128-33.
18. Krüger C, Rauh M, Doerr HG. Immunoreactive renin concentrations in healthy children from birth to adolescence. Clin Chim Acta 1998;274:15-17.
19. Dillon MJ, Gillin ME, Ryness JM, et al. Plasma renin activity and aldosterone concentration in the human newborn. Arch Dis Child 1976;51:537-40.
20. Fiselier TJW, Lijnen P, Monnens L, et al. Levels of renin, angiotensin I and II, angiotensin-converting enzyme and aldosterone in infancy and child hood. Eur J Pediatr 1983;141:3-7.
21. Holmström H, Hall C, Thaulow E. Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr 2001;90:184-91.
22. Redfield MM, Rodeheffer Pd, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976-82.
23. Clark BA, Elahi D, Epstein FH. The influence of gender, age, and the menstrual cycle on plasma atrial natriuretic peptide. J Clin Endocrinol Metab 1990;70:349-52.
24. Danser AH, Derkx FH, Schalekamp MA, et al. Determinants of interindividual variation of renin and prorenin concentrations: evidence of a sexual dimorphism of (pro)renin levels in humans. J Hypertens 1998;16:853-62.
25. Hong M, Yan Q, Tao B, et al. Estradiol, progesterone and testosterone exposures affect the atrial natriuretic peptide gene expression in vivo in rats. Biol Chem Hoppe Seyler 1992;373:213-18.
26. Shih HC, Chao L, Chao J. Age and hormonal dependence of tonin levels in rat submandibular gland as determined by a new direct radioimmunoassay. Biochem J 1986;238:145-9.
27. Vogeser M, Jacob K. B-type natriuretic peptide (BNP) - validation of an immediate response assay. Clin Lab 2001;47:29-33.
28. McNairy M, Gardetto N, Clopton P, et al. Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: implications for outpatient monitoring with B-type natriuretic peptide. Am Heart J 2002;143:406-11.
29. Vasan RS, Banjamin EJ, Larson MG, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction. The Framingham Heart Study. JAMA 2002;288:1252-9.